BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4471076)

  • 1. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
    Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravascular coagulation of the blood in liver cirrhosis (a review of the literature)].
    Shelest LIu; Sushko EA; Shkapko VD; Shekhter IE; Ena IaM
    Vrach Delo; 1990 Aug; (8):44-7. PubMed ID: 2256285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
    Raschka C; Róka L
    Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 9. What role does the measurement of fibrinogen and its derivatives have in the diagnosis of disseminated intravascular coagulation?
    Dempfle CE
    Blood Rev; 2002 Dec; 16 Suppl 1():S23-8. PubMed ID: 12918784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
    van Outryve M; Baele G; de Weerdt GA; Barbier F
    Scand J Haematol; 1973; 11(2):148-52. PubMed ID: 4773962
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?
    Cioni G; Cristani A; Vignoli A; Ventura E
    Recenti Prog Med; 1994 Apr; 85(4):230-4. PubMed ID: 8016448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical studies in the postmortem diagnosis of the disseminated intravascular coagulation syndrome].
    Avramenko EP; Zoroastrov OM; Galian SL; Gladyshev SP; Lotter MG
    Sud Med Ekspert; 1998; 41(3):17-9. PubMed ID: 9703738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
    Buraschi J; Sack ES
    Sangre (Barc); 1972; 17(1):35-42. PubMed ID: 5016795
    [No Abstract]   [Full Text] [Related]  

  • 19. [Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():600-3. PubMed ID: 15658400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
    Génova V; Georgief Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):300-12. PubMed ID: 4136341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.